Bartlett & Co. LLC Rebus Holdings, Inc. Call Options Transaction History

Bartlett & Co. LLC

  • $6.16 Billion
  • Q4 2023

Call Options

0 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
No transaction found.

Others Institutions Holding RBSH

# of Institutions
1
Shares Held
2
Call Options Held
0
Put Options Held
0
View Full List

About Rebus Holdings, Inc.

RBSH Quotes by TradingView
  • Ticker RBSH
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 32,132,900
  • Description
  • Rebus Holdings, Inc. focuses on the research and development of precision therapeutics for the treatment of cancer. Its lead asset is RT-AR001, an adenosine receptor antagonist for tumor infiltration and enhanced outcomes when administered intra-tumorally. The company was founded in 2003 and is based in Westlake Village, California.
More about RBSH
Track This Portfolio

Track Bartlett & Co. LLC Portfolio

Follow Bartlett & Co. LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bartlett & Co. LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bartlett & Co. LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email